BRAF and thyroid gland carcinoma: Recently, genetic and molecular analyses (such as tests for BRAF, RET/PTC, and RAS, among others) revealed diverse molecular characteristics of thyroid cancers, but most clinical trials applying RA did not analyze these factors.